GSK-3β protein is a direct substrate of PI3K/Akt [37], which plays an essential role in the regulation of AD, and the adjustment of this pathway can reduce apoptosis and delay the development of AD, which may be one of the factors that improve cognitive function in terms of the molecular biological mechanism. Here, AKT1 is linked to Alzheimer disease.